Plandaí chief executive officer Roger Duffield said the anecdotal benefits of green tea have been known for centuries, with herbalists using it to benefit cardiovascular health and help
As per the agreement, Abbott manufactures all dosage strengths of the authorized generic product and supplies to Watson. Watson markets and distributes the product in the US and
The protocol template of the Phase II trial of lisinopril is currently available on a prototype of the company’s crowdsourced web platform. The web platform allows patients, physicians,
The new Twinlab Bariatric Support line is formulated to address the nutritional needs of bariatric surgery patients and support them in their efforts to live a healthy lifestyle.
BioClinica OnPoint CTMS helps clinical trial sponsors to consolidate and share the data, while improving trial management by using Microsoft SharePoint 2010 and Microsoft Office 2010. BioClinica CEO
Under the collaboration, Fast Forward will fund the preclinical advancement of Concert’s C-21191, a deuterium-modified subtype-selective GABAA modulator. Fast Forward and National MS Society chief research officer Timothy
Eclinso’s trialforce Platform and XClinical’s Electronic Data Capture (EDC) system, Marvin, offer unparalleled flexibility and adaptability to both Sponsors and Clinical Research Organizations (CROs) for capturing and managing
The comparator-controlled study, conducted in Australia under its contract with the US Department of Health and Human Services’ Office of Biomedical Advanced Research and Development Authority, will enroll
The gluten free supplement is available in three delicious flavors chocolate, vanilla and cookies & creme. The company claims that each serving of the product contains 27gm of
Ublituximab is a third generation chimeric monoclonal antibody targeting an epitope on the CD20 antigen found on B lymphocytes. TG has announced the closing of a capital raise,
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.